The airway mycobiome and interactions with immunity in health and chronic lung disease.
| Autor: | Katsoulis O; Centre for Bacterial Resistance Biology, Department of Infectious Disease, Imperial College London, London SW7 2DD, UK., Pitts OR; Centre for Bacterial Resistance Biology, Department of Infectious Disease, Imperial College London, London SW7 2DD, UK., Singanayagam A; Centre for Bacterial Resistance Biology, Department of Infectious Disease, Imperial College London, London SW7 2DD, UK.; National Heart and Lung Institute, Imperial College London, London SW7 2DD, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Oxford open immunology [Oxf Open Immunol] 2024 Aug 22; Vol. 5 (1), pp. iqae009. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024). |
| DOI: | 10.1093/oxfimm/iqae009 |
| Abstrakt: | The existence of commensal fungi that reside within the respiratory tract, termed the airway mycobiome, has only recently been discovered. Studies are beginning to characterize the spectrum of fungi that inhabit the human upper and lower respiratory tract but heterogeneous sampling and analysis techniques have limited the generalizability of findings to date. In this review, we discuss existing studies that have examined the respiratory mycobiota in healthy individuals and in those with inflammatory lung conditions such as asthma, chronic obstructive pulmonary disease and cystic fibrosis. Associations between specific fungi and features of disease pathogenesis are emerging but the precise functional consequences imparted by mycobiota upon the immune system remain poorly understood. It is imperative that further research is conducted in this important area as a more detailed understanding could facilitate the development of novel approaches to manipulating the mycobiome for therapeutic benefit. (© The Author(s) 2024. Published by Oxford University Press.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|